US7815923B2
Active / In Force
US
⏱️ 0.2 years remaining
Implantable graft material
Assignee: Cook Biotech Inc
•
Filing: 2006-12-26
•
Granted: 2010-10-19
•
Expires: 2026-12-26
Abstract
Abstract Described are graft materials suitable for implantation within a patient including isolated tissue material remodeled in a body cavity. Also described are methods of treating a patient that include implanting these materials and prosthetic devices comprising these materials within the patient's body.
Inventors
- 👤 Chad E. Johnson
- 👤 Michael C. Hiles
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:29
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2412; A61F2/2415; A61F2/04; A61F2/06; A61F2/0095; A61F2/2475; A61F2/82; A61L; A61L27/00; A61L27/36; A61L27/3604; A61L27/3633; A61L27/3641; A61L27/3645; A61L27/3683; A61L27/38; A61L27/3804; A61L27/3839; A61L27/3843; A61L31/00; A61L31/005; C; C12; C12N; C12N5/00; C12N5/0068; A61B; A61B50/00; A61B2050/005; A61B2050/0065; A61B90/00; A61B90/90; A61F2/07; A61F2/08; A61F2/30; A61F2/32; A61F2/36; A61F2/3601; A61F2/3603; A61F2/40; A61F2/86; A61F2002/072; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/30062; A61F2002/30108; A61F2002/30199; A61F2002/30242; A61F2002/30245; A61F2002/30316; A61F2002/30535; A61F2002/30593; A61F2002/30621; A61F2002/30649; A61F2/30721; A61F2002/30754; A61F2/3094; A61F2002/30971; A61F2/4003; A61F2002/4007; A61F2210/00; A61F2210/0004; A61F2230/00; A61F2230/0063; A61F2230/0071; A61F2240/00; A61F2240/001; A61F2310/00; A61F2310/00005; A61F2310/00365
Claims Analysis
Total Claims: 57
Claim 1
Independent Claim
146 words
An isolated graft material retaining a valve cusp shape for providing a valve cusp for contacting and modifying fluid flow in a body passageway, said isolated graft material prepared by a process comprising removing from a body cavity of a host a tissue material resulting from remodeling of a previously inserted amount of a remodelable extracellular matrix material in the body cavity, the remodelable extracellular matrix material being associated with an implanted shaping element in the body cavity and being effective, upon insertion in said body cavity, to stimulate the ingrowth of native cells into the remodelable extracellular matrix material such that the remodelable extracellular matrix material becomes infiltrated and replaced by newly formed host tissue, wherein said remodeling of said previously inserted amount of remodelable extracellular matrix material in association with said implanted shaping element causes said graft material to retain said valve cusp shape.
Claim 2
Dependent Claim
146 words
An isolated graft material retaining a valve cusp shape for providing a valve cusp for contacting and modifying fluid flow in a body passageway, said isolated graft material prepared by a process comprising removing from a body cavity of a host a tissue material resulting from remodeling of a previously inserted amount of a remodelable extracellular matrix material in the body cavity, the remodelable extracellular matrix material being associated with an implanted shaping element in the body cavity and being effective, upon insertion in said body cavity, to stimulate the ingrowth of native cells into the remodelable extracellular matrix material such that the remodelable extracellular matrix material becomes infiltrated and replaced by newly formed host tissue, wherein said remodeling of said previously inserted amount of remodelable extracellular matrix material in association with said implanted shaping element causes said graft material to retain said valve cusp shape.
Claim 3
Dependent Claim
27 words
The isolated graft material of claim 1 , wherein said remodelable extracellular matrix material retains bioactive components native to a source tissue for the extracellular matrix material.
Claim 4
Dependent Claim
52 words
The isolated graft material of claim 2 , wherein said remodelable extracellular matrix material comprises at least 80% by weight collagen on a dry weight basis, includes uniaxial or multiaxial oriented fibers, and includes at least about 3% retained non-collagenous solids from the source tissue, the non-collagenous solids including said bioactive components.
Claim 5
Dependent Claim
15 words
The isolated graft material of claim 2 , wherein the bioactive components comprise growth factors.
Claim 6
Dependent Claim
34 words
The isolated graft material of claim 1 , wherein said remodelable extracellular matrix material includes a section that is held in tension against a surface of said implanted shaping element in said body cavity.
Claim 7
Dependent Claim
13 words
The isolated graft material of claim 1 coupled to an implantable valve frame.
Claim 8
Dependent Claim
23 words
The isolated graft material of claim 1 further providing a generally hollow, tubular graft which incorporates said valve cusp within said tubular graft.
Claim 9
Dependent Claim
25 words
The isolated graft material of claim 1 , wherein said remodelable extracellular matrix material is further associated with a frame element in said body cavity.
Claim 10
Independent Claim
167 words
A method of forming an isolated graft material suitable for implantation in the body of a patient, the method comprising removing from a body cavity of a host a tissue material resulting from remodeling of a previously inserted amount of a remodelable extracellular matrix material in the body cavity, the remodelable extracellular matrix material being associated with an implanted shaping element in the body cavity and being effective, upon insertion in said body cavity, to stimulate the ingrowth of native cells into the remodelable extracellular matrix material such that the remodelable extracellular matrix material becomes infiltrated and replaced by newly formed host tissue, wherein said remodeling of said previously inserted amount of remodelable extracellular matrix material in association with said implanted shaping element causes said tissue material to retain a valve cusp shape for providing a valve cusp for contacting and modifying fluid flow in a body passageway, or an elongate generally cylindrical shape having a generally solid cross section for providing a prosthetic ligament or tendon.
Claim 11
Independent Claim
167 words
A method of forming an isolated graft material suitable for implantation in the body of a patient, the method comprising removing from a body cavity of a host a tissue material resulting from remodeling of a previously inserted amount of a remodelable extracellular matrix material in the body cavity, the remodelable extracellular matrix material being associated with an implanted shaping element in the body cavity and being effective, upon insertion in said body cavity, to stimulate the ingrowth of native cells into the remodelable extracellular matrix material such that the remodelable extracellular matrix material becomes infiltrated and replaced by newly formed host tissue, wherein said remodeling of said previously inserted amount of remodelable extracellular matrix material in association with said implanted shaping element causes said tissue material to retain a valve cusp shape for providing a valve cusp for contacting and modifying fluid flow in a body passageway, or an elongate generally cylindrical shape having a generally solid cross section for providing a prosthetic ligament or tendon.
Claim 12
Dependent Claim
24 words
The method of claim 9 , wherein the tissue material is removed from the body cavity at least 15 days after being inserted therein.
Claim 13
Dependent Claim
25 words
The method of claim 9 , wherein the tissue material is removed from the body cavity no later than 45 days after being inserted therein.
Claim 14
Dependent Claim
24 words
The method of claim 9 , wherein the tissue material is removed from the body cavity at least 25 days after being inserted therein.
Claim 15
Dependent Claim
25 words
The method of claim 9 , wherein said remodelable extracellular matrix material retains bioactive components native to a source tissue for the extracellular matrix material.
Claim 16
Dependent Claim
50 words
The method of claim 13 , wherein said remodelable extracellular matrix material comprises at least 80% by weight collagen on a dry weight basis, includes uniaxial or multiaxial oriented fibers, and includes at least about 3% retained non-collagenous solids from the source tissue, the non-collagenous solids including said bioactive components.
Claim 17
Independent Claim
94 words
A method of forming an isolated, decellularized tissue material, the method comprising: removing from a body cavity of a host a tissue material resulting from remodeling of a previously inserted amount of a remodelable extracellular matrix material in the body cavity, the remodelable extracellular matrix material being effective, upon insertion in said body cavity, to stimulate the ingrowth of native cells into the remodelable extracellular matrix material such that the remodelable extracellular matrix material becomes infiltrated and replaced by newly formed host tissue; and decellularizing the tissue material following removal from said body cavity.
Claim 18
Independent Claim
94 words
A method of forming an isolated, decellularized tissue material, the method comprising: removing from a body cavity of a host a tissue material resulting from remodeling of a previously inserted amount of a remodelable extracellular matrix material in the body cavity, the remodelable extracellular matrix material being effective, upon insertion in said body cavity, to stimulate the ingrowth of native cells into the remodelable extracellular matrix material such that the remodelable extracellular matrix material becomes infiltrated and replaced by newly formed host tissue; and decellularizing the tissue material following removal from said body cavity.
Claim 19
Dependent Claim
17 words
The method of claim 15 , wherein said tissue material is in the form of a sheet.
Claim 20
Dependent Claim
17 words
The method of claim 15 , wherein said tissue material is in the form of a tube.
Claim 21
Dependent Claim
11 words
The method of claim 17 , wherein said tube is hollow.
Claim 22
Dependent Claim
16 words
The method of claim 15 , wherein said tissue material provides one or more valve leaflets.
Claim 23
Dependent Claim
20 words
The method of claim 15 , wherein said tissue material is in the form of a prosthetic ligament or tendon.
Claim 24
Dependent Claim
28 words
The method of claim 15 , wherein said remodelable extracellular matrix material was seeded with one or more cell populations prior to being inserted in said body cavity.
Claim 25
Dependent Claim
22 words
The method of claim 15 , wherein said remodelable extracellular matrix material is associated with a frame element in said body cavity.
Claim 26
Dependent Claim
15 words
The method of claim 22 , wherein said frame element comprises one or more stents.
Claim 27
Dependent Claim
32 words
The method of claim 23 , wherein said one or more stents includes a plurality of discrete, spaced stents which are embedded within and interconnected to one another by said tissue material.
Claim 28
Dependent Claim
19 words
The method of claim 15 , wherein said isolated, decellularized tissue material is adapted for implantation in a joint.
Claim 29
Dependent Claim
15 words
The method of claim 15 , wherein said body cavity is that of a vertebrate.
Claim 30
Dependent Claim
19 words
The method of claim 26 , wherein said body cavity is that of a bovine, equine, ovine, or porcine.
Claim 31
Dependent Claim
15 words
The method of claim 26 , wherein said body cavity is that of a human.
Claim 32
Dependent Claim
14 words
The method of claim 15 , wherein said body cavity is a peritoneal cavity.
Claim 33
Dependent Claim
20 words
The method of claim 15 , wherein said body cavity is a thoracic cavity, scrotum, brain, joint, or pericardial cavity.
Claim 34
Dependent Claim
23 words
The method of claim 15 , wherein said remodelable extracellular matrix material is associated with an implanted shaping element in the body cavity.
Claim 35
Dependent Claim
13 words
The method of claim 31 , wherein said implanted shaping element is biodegradable.
Claim 36
Dependent Claim
25 words
The method of claim 31 further comprising separating said shaping element from said graft material after said graft material is removed from said body cavity.
Claim 37
Dependent Claim
32 words
The method of claim 31 , wherein said isolated, decellularized tissue material retains a valve cusp shape for providing a valve cusp for contacting and modifying fluid flow in a body passageway.
Claim 38
Dependent Claim
22 words
The method of claim 15 , wherein said remodelable extracellular matrix material is located inside a shaping mold in said body cavity.
Claim 39
Dependent Claim
23 words
The graft material of claim 35 , wherein a wall of said shaping mold is perforated to allow fluid access through said wall.
Claim 40
Dependent Claim
15 words
The method of claim 35 , wherein said shaping mold comprises a hollow tubular mold.
Claim 41
Dependent Claim
21 words
The method of claim 37 , wherein said remodelable extracellular matrix material is received within and fills said hollow tubular mold.
Claim 42
Dependent Claim
30 words
The method of claim 15 , wherein said isolated, decellularized graft material provides an elongate graft body having a generally solid cross section for providing a prosthetic ligament or tendon.
Claim 43
Dependent Claim
29 words
The method of claim 15 , wherein said remodelable extracellular matrix material comprises a sheet of remodelable extracellular matrix material obtained in sheet form from a collagenous tissue source.
Claim 44
Dependent Claim
27 words
The method of claim 40 , wherein said remodelable extracellular matrix sheet material retains bioactive components native to a source tissue for the extracellular matrix sheet material.
Claim 45
Dependent Claim
51 words
The method of claim 41 , wherein said remodelable extracellular matrix sheet material comprises at least 80% by weight collagen on a dry weight basis, includes uniaxial or multiaxial oriented fibers, and includes at least about 3% retained non-collagenous solids from the source tissue, the non-collagenous solids including said bioactive components.
Claim 46
Dependent Claim
33 words
The method of claim 40 , wherein said remodelable extracellular matrix sheet material includes a section that is held in tension against a surface of an implanted shaping element in said body cavity.
Claim 47
Dependent Claim
12 words
The method of claim 43 , wherein said surface is generally cylindrical.
Claim 48
Dependent Claim
12 words
The method of claim 43 , wherein said surface is generally planar.
Claim 49
Dependent Claim
28 words
The method of claim 43 , wherein said section, when held in tension against said surface of said implanted shaping element, takes the shape of a valve cusp.
Claim 50
Dependent Claim
39 words
The method of claim 46 , wherein said valve cusp shape is maintained during remodeling of the remodelable extracellular matrix material such that said valve cusp shape is generally retained by said section after removal from the body cavity.
Claim 51
Dependent Claim
169 words
An isolated tissue material suitable for implantation in the body of a patient, said isolated tissue material prepared by a process comprising removing from a body cavity of a host a tissue material resulting from remodeling of a previously inserted amount of a remodelable extracellular matrix material in the body cavity, the remodelable extracellular matrix material being associated with an implanted shaping element in the body cavity and being effective, upon insertion in said body cavity, to stimulate the ingrowth of native cells into the remodelable extracellular matrix material such that the remodelable extracellular matrix material becomes infiltrated and replaced by newly formed host tissue, wherein said remodeling of said previously inserted amount of remodelable extracellular matrix material in association with said implanted shaping element causes said tissue material to retain a valve cusp shape for providing a valve cusp for contacting and modifying fluid flow in a body passageway, or an elongate generally cylindrical shape having a generally solid cross section for providing a prosthetic ligament or tendon.
Claim 52
Dependent Claim
169 words
An isolated tissue material suitable for implantation in the body of a patient, said isolated tissue material prepared by a process comprising removing from a body cavity of a host a tissue material resulting from remodeling of a previously inserted amount of a remodelable extracellular matrix material in the body cavity, the remodelable extracellular matrix material being associated with an implanted shaping element in the body cavity and being effective, upon insertion in said body cavity, to stimulate the ingrowth of native cells into the remodelable extracellular matrix material such that the remodelable extracellular matrix material becomes infiltrated and replaced by newly formed host tissue, wherein said remodeling of said previously inserted amount of remodelable extracellular matrix material in association with said implanted shaping element causes said tissue material to retain a valve cusp shape for providing a valve cusp for contacting and modifying fluid flow in a body passageway, or an elongate generally cylindrical shape having a generally solid cross section for providing a prosthetic ligament or tendon.
Claim 53
Dependent Claim
24 words
The isolated tissue material of claim 48 , wherein said remodelable extracellular matrix material comprises serosa, pericardium, submucosa, dura mater, peritoneum, or dermal collagen.
Claim 54
Dependent Claim
23 words
The isolated tissue material of claim 48 , wherein said tissue material comprises said remodelable extracellular matrix material remodeled in said body cavity.
Claim 55
Dependent Claim
15 words
The isolated tissue material of claim 48 further comprising mesothelial cells from said body cavity.
Claim 56
Dependent Claim
14 words
The isolated tissue material of claim 48 further comprising myofibroblasts from said body cavity.
Claim 57
Dependent Claim
12 words
The isolated tissue material of claim 48 provided in a decellularized state.
References Cited (Backward Citations)
US3514791A
Cited
US4218782A
Cited
US4902508A
Cited
US4956178A
Cited
US6582462B1
Cited
US20030036795A1
Cited
US5411552A
Cited
US6168614B1
Cited
US5156620A
Cited
US5281422A
Cited
US5489297A
Cited
US5607465A
Cited
US5955110A
Cited
US5554389A
Cited
US5855601A
Cited
US6206931B1
Cited
US6096347A
Cited
US6099567A
Cited
US6126686A
Cited
US6187039B1
Cited
US6475232B1
Cited
US6358284B1
Cited
US6287334B1
Cited
US20040015230A1
Cited
US6200336B1
Cited
US6508833B2
Cited
US20010011187A1
Cited
US6352555B1
Cited
US6626823B1
Cited
WO2000023008A2
Cited
US6110201A
Cited
US20010039450A1
Cited
WO2001010355A1
Cited
US6299637B1
Cited
WO2001019285A1
Cited
US20030130726A1
Cited
US20020188348A1
Cited
WO2001037884A2
Cited
US20040049262A1
Cited
US20050267560A1
Cited
US20030208261A1
Cited
US6454799B1
Cited
US20040106991A1
Cited
WO2001078754A2
Cited
WO2001085226A1
Cited
US20020123800A1
Cited
US20040193253A1
Cited
WO2003070124A2
Cited
US6716241B2
Cited
US6752828B2
Cited
US20030191525A1
Cited
WO2004082528A2
Cited
WO2005011534A1
Cited
WO2005020847A2
Cited
WO2005089673A1
Cited
US20050228486A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2013-10-18 | 2014-04-19 | 2014-10-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2017-10-18 | 2018-04-19 | 2018-10-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2021-10-18 | 2022-04-19 | 2022-10-19 | $7700.00 | Window Closed / Lapsed |